Lymphoma (Burkitt, Hodgkin, and non-Hodgkin)
DCEG researchers conduct studies and participate in consortial activities on cancers of the white blood cells, known as lymphomas. DCEG's portfolio includes studies of Burkitt lymphoma, Hodgkin lymphoma, and non-Hodgkin lymphoma and its subtypes. Selected studies and consortia include:
Research Studies
-
AsiaLymph Study
A hospital-based case-control study of 3,000 cases of NHL and 3,000 controls in Asia that is exploring occupational and environmental exposures, viral infections, and genetic susceptibility
-
Epidemiology of Burkitt Lymphoma in East African Children and Minors (EMBLEM)
A large, population-based study of BL conducted in six rural areas in Uganda, Tanzania, and Kenya to investigate the role of P. falciparum, Epstein-Barr virus (EBV) and host genetic factors in childhood Burkitt lymphoma (BL).
-
NCI-SEER Non-Hodgkin Lymphoma (NHL) Case-Control Study
Studies to identify common genetic variants in relation to both NHL susceptibility and survival within the NCI-SEER NHL Study
-
Pooled Analysis of Studies of Non-Hodgkin Lymphoma
A pooled analysis of case-control studies of non-Hodgkin lymphoma among men from Iowa, Minnesota, Kansas, and Nebraska to evaluate potential risks from pesticide and other exposures
Consortial Activities
-
International Lymphoma Epidemiology Consortium (InterLymph)
A consortium designed to enhance collaboration among epidemiologists studying lymphoma, to provide a forum for the exchange of research ideas, and to create a framework for collaborating on analyses that pool data from multiple studies
-
Non-Hodgkin Lymphoma Subtypes Project
An international consortial project to comprehensively evaluate the etiology of 11 non-Hodgkin lymphoma (NHL) subtypes, considering family and medical history, lifestyle and occupational risk factors, and inherited genetic susceptibility.